Industry-Paid Talk Policy
The School of Medicine Policy to Limit Conflicts of Interest Between Health Care Professionals and Industry Representatives prohibits SOM faculty members from accepting free meals, drug samples, travel or gifts from manufacturers of pharmaceuticals, medical devices, nutritional supplements or medical devices.
The policy also prohibits Speakers' Bureau participation by School of Medicine faculty, except in limited circumstances. All industry-paid speaking engagements must be approved, in advance, by the Industry Talk Approval Committee.
Approval of non-marketing speaking engagements will be considered by the Industry Talk Approval Committee if the talk represents a genuine service to the community and is solely for educational purposes. Approval will not be granted for talks that focus on specific products, if the speaker is required to use any slides or other materials provided by industry, or if the slides or other content are subject to approval by industry.
Note: If your talk meets any of the following criteria, your talk is exempted from the Speakers' Bureaus policy and you do not need to submit your talk for approval:
- Research consulting (defined as an activity that focuses on planning, conduct or analysis of a clinical or scientific investigation or dissemination of the results of an investigation performed or coordinated by you).
- Approved Continuing Medical Education (CME) program, and you are allowed to change the content of your slides or presentation without review and approval by industry.
- Compensation for presentation will come directly from an academic institution, non-profit organization, or professional society (e.g., visiting professorships or academic grand rounds).
Process for Requesting Approval of Industry-Paid Speaking Engagements
- Obtain speaking contract or agreement in Word format from the Pharmaceutical Company.
- Complete the Industry Talk Approval Form, and attach the contract within the form. Note: the Industry Talk Approval Committee will not approve a request if the industry contract for the speaking engagement is not included with the request.
SOM Approval Process
- The industry contract may first be reviewed by UPI legal counsel and, if necessary, revised to satisfy University policies.
- Note that the following language, which has been approved by the Industry Talk Approval Committee, must be included in all speaking contracts:
"With regard to any presentation delivered by Speaker at the request of the Company pursuant to this Agreement, Speaker will have exclusive control over the content of any such presentation, including any accompanying presentation materials, handouts, or slides, based on Speaker's expertise and independent, objective professional judgment. The content of such presentations, including any accompanying materials, handouts, or slides, will not be subject to the review or approval of the Company, except that the Company may review handouts, slides and other materials for the sole purpose of ensuring compliance with FDA regulations. In additional, any such presentation will be for the purpose of providing information of general scientific interest and concern, and will not be focused on the marketing and promotion of the Company's products."
- If the contract is revised by legal counsel, it will be returned to the faculty member, and it is the faculty member's responsibility to gain approval of the revised language from the Pharmaceutical Company. The speaking request will not be reviewed by the Industry Talk Approval Committee until the revised contract is approved by the Pharmaceutical Company and resubmitted to the Committee.
- Once Committee has received a finalized contract and speaker request, they will review the request and respond to faculty member within 10 business days.
Direct any questions to Cheryl Welch.
Other Important Policies and Documents